Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Quantum rods (QRs) offer unique optical properties for biomedical imaging.
• Targeted delivery systems are crucial for effective cancer diagnosis and therapy.
• Developing biocompatible and non-toxic imaging agents is essential for in vivo applications.

Purpose of the Study:

• To develop and evaluate luminescent quantum rods (QRs) conjugated with cyclic RGD peptides for targeted tumor imaging.
• To assess the in vivo performance, biodistribution, and safety of these targeted QR probes in a preclinical cancer model.

Main Methods:

• Hydrophobic CdSe/CdS/ZnS QRs were encapsulated in PEGylated phospholipids.
• PEGylated phospholipids were conjugated with cyclic RGD peptides for tumor targeting.
• In vivo optical imaging and cytotoxicity studies were performed in nude mice with pancreatic cancer xenografts.

Main Results:

• Targeted luminescent probes demonstrated accumulation at tumor sites in vivo.
• QR probes exhibited specific binding to alpha(V)beta(3) integrins overexpressed in tumor vasculature.
• No adverse effects were observed, even at high doses, indicating good biocompatibility.

Conclusions:

• Functionalized quantum rods (QRs) are effective, biocompatible, and photostable luminescent probes for targeted tumor imaging.
• These QRs show significant potential for early cancer diagnosis.
• The developed targeted probes offer a promising alternative to existing quantum dots for in vivo imaging.